Back

Prevalence and prognostic significance of restriction versus systolic dysfunction in patients with transthyretin and light chain cardiac amyloidosis

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis: my heart is filled with so much… Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Mattia Zampieri

Meyer University Hospital, Florence (Italy)

4 More presentations in this session

Presentation thumbnail
Patient characteristics and incidence of cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records
Doctor L. Anderson (London, GB)
Abstract Slides Video
Presentation thumbnail
Usefulness of scintigraphy with [99mTc]Tc-DPD for the detection of transthyretin cardiac amyloidosis. Reference centre experience in an endemic area.
Doctor N. Orta (Palma de Mallorca, ES)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance T1 imaging for the diagnosis of cardiac amyloidosis among patients with symptomatic heart failure
Doctor R. Gessner (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis
Mr S. Muller (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac amyloidosis: my heart is filled with so much…
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources